• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Roche Diabetes Care

Insulet sues Roche over diabetes tech patent

May 12, 2021 By Nancy Crotti

Insulet (NSDQ:PODD) is suing Roche Diabetes Care in the U.K., claiming that Roche prematurely began selling tubeless insulin pumps covered by an Insulet patent three years before that patent expires. The trial for the lawsuit, filed in August 2020, began this week in the U.K. High Court. Get the full story on our sister site, Drug Delivery Business […]

Filed Under: Diabetes, Drug-Device Combinations, Legal News, Patent Infringement Tagged With: Insulet, Roche Diabetes Care

BioCorp, Roche launch Mallya smart insulin pen in France

April 13, 2021 By Sean Whooley

BioCorp and Roche Diabetes Care France announced the launch of the Mallya smart insulin pen device in France. Developed by BioCorp, Mallya is an intelligent sensor for insulin injection pens that has CE mark approval in Europe. The platform is compatible with any disposable insulin pen. It enables reliable monitoring for doses selected for injection and it offers […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Biocorp, Roche, Roche Diabetes Care

Roche wins CE Mark for blood glucose reading smartphone app

December 10, 2019 By Chris Newmarker

Roche (SWX: RO,  ROG) today announced that it has obtained a CE Mark for its Accu-Chek SugarView app, which allows a person to read a blood glucose test strip without a meter. The smartphone app, which will be first available on certain phone models via the Google Play Store, instead uses the phone’s camera to […]

Filed Under: Diabetes, Digital Health, Featured, News Well, Regulatory/Compliance Tagged With: CE Mark, Roche, Roche Diabetes Care

Senseonics extends distribution agreement with Roche Diabetes Care

February 4, 2019 By Chris Newmarker

Senseonics Holdings (NYSE-American: SENS) — maker of an implantable continuous glucose monitoring system for people with diabetes — has extended its distribution agreement with Roche Diabetes Care. The agreement extension, announced yesterday, has Roche continuing as Senseonics’ exclusive distributor in Europe, the Middle East and Africa — excluding Scandinavia and Israel. The agreement also adds 17 […]

Filed Under: Business/Financial News, Diabetes, Distribution, News Well Tagged With: Roche Diabetes Care, Senseonics

UK warns about alarm failure for Roche’s insulin pumps

September 20, 2017 By Sarah Faulkner

The UK’s Medicines and Healthcare products Regulatory Agency issued a medical device alert for Roche‘s (OTC:RHHBY) Accu-Check Insight insulin pumps today, warning that the device’s audible and vibration alarms may not function. If a user doesn’t see the notification message on the pump and can’t hear or feel an alarm, it could lead to hyperglycemia, the agency said. […]

Filed Under: Drug Pumps, Drug-Device Combinations, Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Roche, Roche Diabetes Care

Senseonics inks artificial pancreas deal with Roche, TypeZero Technologies

July 25, 2017 By Sarah Faulkner

Senseonics (NYSE:SENS) said today that it inked a collaboration with TypeZero Technologies and Roche (OTC:RHHBY) Diabetes Care to develop an automated insulin delivery system. The deal is part of an NIH-funded effort to test artificial pancreas systems. The trial is slated to integrate Senseonic’s Eversense glucose monitor, TypeZero’s inControl AP algorithms and Roche’s Accu-Chek Insight insulin pump. The software automatically […]

Filed Under: Diabetes, Drug-Device Combinations, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: Roche Diabetes Care, Senseonics, TypeZero Technologies

Roche launches Accu-Check Guide blood glucose meter

May 26, 2017 By Fink Densford

Roche (PINK:RHHBY) this week said it launched the Accu-Chek Guide System blood glucose meter. The company said that the Accu-Chek Guide meter is designed to help simplify diabetes management, featuring a spill-resistant test-strip vial, a large blood application area and strip ports for checks at different times during the day. The Accu-Chek Guide System is designed […]

Filed Under: Diabetes Tagged With: Roche Diabetes Care

Roche denies rumors it will shop diabetes unit, earnings

February 1, 2017 By Sarah Faulkner

Roche (PINK:RHHBY) denied rumors that it was considering selling its diabetes unit today, saying that it is “committed” to the business. The company also predicted that competition and spending on new drugs would stall its margin growth in 2017, as patents expire for its blockbuster medications. The Swiss drugmaker’s 3 top-selling cancer drugs, Rituxan, Herceptin and […]

Filed Under: Diabetes, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Roche, Roche Diabetes Care

Danaher lures ex-Medtronic legal eagle Ellis for GC spot | Personnel Moves

November 30, 2015 By Brad Perriello

Danaher (NYSE:DHR) said it lured Brian Ellis from Medtronic (NYSE:MDT) to be its new general counsel, replacing Jonathan Graham, who jumpoed ship for Amgen (NSDQ:AMGN) last May. Ellis was general counsel for Medtronic’s restorative therapies group, after stints as GC and chief compliance officer for monitoring solutions at GE Healthcare (NYSE:GE) “Brian brings a wealth of experience leading and […]

Filed Under: Business/Financial News Tagged With: Akers Biosciences, Alphatec, becton dickinson, Danaher Corp., Invacare, InVivo Therapeutics, Invuity, LifeMap, Medtronic, Nuvasive, Personnel Moves, Roche Diabetes Care, Sensium, tandemdiabetes, Teleflex, Uluru

Diabetes: FDA OKs 1st glucose meter with insulin calculator

September 18, 2014 By Arezu Sarvestani

Diabetes: FDA OKs 1st glucose meter with insulin calculator

Biotech titan Roche secured a landmark FDA win with clearance for its Accu-Chek Aviva Expert blood glucose meter, the 1st of its kind with a built-in insulin calculator to help guide patient therapy.

Filed Under: Diabetes, News Well Tagged With: Press Release, Roche, Roche Diabetes Care

Press Release: ACCU-CHEK Aviva Expert, the first and only stand-alone blood glucose meter system with a built-in insulin calculator, is now available

September 18, 2014 By MassDevice Leave a Comment

Press Release: ACCU-CHEK Aviva Expert, the first and only stand-alone blood glucose meter system with a built-in insulin calculator, is now available

Filed Under: News Well Tagged With: Press Release, Roche, Roche Diabetes Care

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS